Just a few days left to Make Your Holiday!
Check order deadlines

<div class="sw-email-modal sw--display-block"> <div id="emailModalContentContainer"> <span class="noty_close sw--position-absolute sw--position-right sw--padding-top-3 sw--padding-right-3 icon-cancel sw--opacity-8"></span> <div class="sw-row"> <div class="sw-email-modal__copy sw--position-relative sw--display-block sw--padding-vert-4"> <p class="last sw--font-size-16">Sign up to get email alerts on discount promotions. There might be one very soon...</p> <form action="/register/email-signup" class="sw-email-modal__signup sw--position-relative" data-confirmation="emailConfirmationModal" data-sw-email-modal-form> <input type="text" class="sw-email-modal__signup-input sw--input-height__medium" placeholder="Email address" name="email" /> <input type="hidden" class="sw-email-modal__signup-input" name="location" value="/product/5DRW5AENS/rotigotine-form-ii" /> <input type="hidden" class="sw-email-modal__signup-input" name="confirmation" value="emailConfirmationModal" /> <input type="submit" class="btn-primary" value="Sign Up" /> <div id="emailModalFormError" class="text-error" style="display:none"></div> </form> </div> </div> </div>

Click and drag to rotate
Rotigotine Form II 3d printed

Not a Photo

Full Color Sandstone
Rotigotine Form II 3d printed
Rotigotine Form II 3d printed

Not a Photo

Rotigotine Form II

Made By
  Will arrive by Dec 23 in this material. Details
  • 3D printed in Full Color Sandstone: Fully colored material with a coarse finish and a delicate feel.
  • Be the first to try. Learn more
  • This product is intended for mature audiences.
Share Link
Embed This Product

Product Description


Rotigotine (Neupro) is a dopamine agonist of the non-ergoline class of medications indicated for the treatment of Parkinson's disease (PD) and restless legs syndrome (RLS). Rotigotine was first developed in 1985 as N-0427 by a team from the University of Groningen. Development was then continued by Aderis Pharmaceuticals. In 1998, Aderis licensed worldwide development and commercialization rights for rotigotine to the German pharmaceutical company Schwarz Pharma (today a subsidiary of the Belgian company UCB S.A.). Rotigotine is known to exist in two polymorphic forms that have significantly different properties. See “Unexpected Polymorphism with Predictable Overall Monotropic Behavior.", Rietveld IB, Céolin R, J Pharm Sci. 2015 Dec;104(12):4117-22. doi: 10.1002/jps.24626 and “Novel polymorphic form of rotigotine and process for production” , Hans-Michael Wolff, Luc Quere, Jens Riedner US 20090143460 A1


What's in the Box
Rotigotine Form II
Full Color Sandstone
8.5 cm
9.1 cm
10.2 cm

Sign In or Join to comment.


We're sorry to inform you that we no longer support this browser and can't confirm that everything will work as expected. For the best Shapeways experience, please use one of the following browsers:

Click anywhere outside this window to continue.